Invesco Pharmaceuticals ETF
PJP
87 hedge funds and large institutions have $75.1M invested in Invesco Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 27 reducing their positions, and 7 closing their positions.
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
5% more funds holding
Funds holding: 83 → 87 (+4)
4% more capital invested
Capital invested by funds: $72.2M → $75.1M (+$2.91M)
0.87% less ownership
Funds ownership: 22.37% → 21.5% (-0.87%)
33% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$537K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$407K |
| 3 |
AWMS
Advocacy Wealth Management Services
Atlanta,
Georgia
|
+$398K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$277K |
| 5 |
SB
Strategic Blueprint
Atlanta,
Georgia
|
+$254K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$2.07M |
| 2 |
Morgan Stanley
New York
|
-$1.33M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.25M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$682K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$334K |
PJP Hedge Fund Activity: Q4 2020 in Review
87 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2020, worth a combined $75.1M — up 4% from $72.2M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PJP positions and 7 closed out — a net gain of 8 holders — while 18 added to existing stakes and 27 trimmed.
The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $537K. The largest seller was Flow Traders U.S., exiting entirely with an estimated $2.07M sold.
- 87 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2020, up from 83 in Q3 2020.
- Funds reported $75.1M of Invesco Pharmaceuticals ETF stock for Q4 2020, up 4% quarter-over-quarter.
- 15 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2020 and 7 closed out, a net change of +8 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2020 was Northwestern Mutual Wealth Management, an estimated $537K added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2020 was Flow Traders U.S., an estimated $2.07M sold.
Based on aggregated 13F filings for Q4 2020.